Abstract
BACKGROUND: Male lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement (BPE) represent a common urological condition, especially in older males. Literature supports a strong association between male LUTS/BPE and sexual dysfunction. While transurethral resection of the prostate is often considered the standard for male LUTS/BPE surgical treatment, it causes complications across various male sexual domains, such as erectile dysfunction and ejaculatory disorders. In recent years, there have been considerable advances in minimally invasive surgical treatments (MISTs) for male LUTS/BPE. Published literature has shown that MISTs can improve various parameters of voiding domains while minimizing adverse sexual effects. OBJECTIVE: This article provides an overview of the present understanding of the association between male LUTS/BPE and sexual dysfunction, and the present commercially available MISTs, with a specific focus on sexual function outcomes. CONCLUSION: Present MISTs for male LUTS/BPE have demonstrated considerable improvements in various urinary parameters while minimizing adverse effects across different sexual function domains.